Exodus Point Capital Management, LP Oncocyte Corp Call Options Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCX
# of Institutions
4Shares Held
1.16MCall Options Held
0Put Options Held
0-
Awm Investment Company, Inc. New York, NY754KShares$2.23 Million0.33% of portfolio
-
Act Capital Management, LLC Wayne, PA330KShares$976,8000.33% of portfolio
-
Defender Capital, Llc.55.9KShares$165,4190.06% of portfolio
-
American Portfolios Advisors Holbrook, NY21.8KShares$64,6160.0% of portfolio
About Oncocyte Corp
- Ticker OCX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,609,000
- Market Cap $351M
- Description
- OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....